|
|
xv | |
|
|
xvii | |
|
1 What's it all about? A legacy for the next generation of scholars in evolutionary medicine and paleopathology |
|
|
1 | (16) |
|
|
|
|
|
|
1 | (1) |
|
1.2 Paleopathology and medicine |
|
|
2 | (1) |
|
|
3 | (2) |
|
|
5 | (6) |
|
1.4.1 Co-evolution of host and pathogen |
|
|
5 | (2) |
|
1.4.2 Constraints on selection |
|
|
7 | (1) |
|
1.4.3 Mismatch with current industrialised societies |
|
|
8 | (2) |
|
1.4.4 Physiological defences |
|
|
10 | (1) |
|
1.4.5 Reproduction at the expense of health |
|
|
10 | (1) |
|
|
11 | (1) |
|
1.5 The One Health Initiative and future directions |
|
|
11 | (1) |
|
|
12 | (5) |
|
|
12 | (5) |
|
2 Developmental origins of health and disease (DOHaD): perspectives from bioarchaeology |
|
|
17 | (25) |
|
|
|
2.1 The developmental origins model in contemporary and past populations |
|
|
17 | (5) |
|
2.1.1 Bioarchaeological evidence |
|
|
18 | (2) |
|
2.1.2 Insights from teeth |
|
|
20 | (2) |
|
2.2 History of development of the DOHaD model |
|
|
22 | (3) |
|
2.2.1 Famine studies relating to DOHaD and bioarchaeology |
|
|
22 | (1) |
|
2.2.2 Development of DOHaD hypotheses |
|
|
23 | (1) |
|
2.2.3 Further development of DOHaD models |
|
|
24 | (1) |
|
2.3 Life course approaches to health |
|
|
25 | (2) |
|
2.3.1 Longitudinal cohort studies and life course analyses in recent populations |
|
|
26 | (1) |
|
2.3.2 Life course approaches in bioarchaeology |
|
|
26 | (1) |
|
2.4 Exploring explanatory mechanisms between early life development and later life health |
|
|
27 | (2) |
|
|
28 | (1) |
|
|
29 | (13) |
|
|
30 | (12) |
|
3 Acquired spinal conditions in humans: the roles of spinal curvature, the shape of the lumbar vertebrae, and evolutionary history |
|
|
42 | (20) |
|
|
|
|
|
42 | (3) |
|
3.2 Adaptations for bipedalism in the human vertebral column and lumbar vertebrae |
|
|
45 | (2) |
|
3.3 Clinical evidence for an impact of spinal and vertebral shape on spinal health |
|
|
47 | (2) |
|
3.4 Palaeopathological and comparative anatomical evidence for an impact of spinal and vertebral shape on spinal health |
|
|
49 | (1) |
|
3.5 Evolutionary origins of vertical intervertebral disc herniation and spondylolysis |
|
|
49 | (3) |
|
3.6 Potential biomechanical explanations for links between vertebral traits and acquired spinal diseases |
|
|
52 | (2) |
|
|
54 | (1) |
|
|
54 | (8) |
|
|
55 | (7) |
|
4 Birthing humans in the past, the present and future: how birth can be approached holistically through an evolutionary medicine lens |
|
|
62 | (17) |
|
|
|
|
62 | (1) |
|
4.2 How does research on childbirth in the past contribute to the understanding of the evolution of health and disease? |
|
|
63 | (3) |
|
4.2.1 The human birth mechanism |
|
|
63 | (1) |
|
4.2.2 The obstetric dilemma |
|
|
64 | (2) |
|
4.3 How do bioarchaeology and paleopathology offer unique perspectives on childbirth? |
|
|
66 | (4) |
|
|
66 | (2) |
|
4.3.2 Birth in past populations |
|
|
68 | (1) |
|
4.3.3 The siren song of `parturition' scarring |
|
|
68 | (1) |
|
4.3.4 Estimating birth-related mortality in the past |
|
|
69 | (1) |
|
4.4 How can knowledge of the past contribute to modern clinical research on childbirth and obstetric medicine? |
|
|
70 | (3) |
|
|
73 | (6) |
|
|
73 | (6) |
|
5 Isotopic reconstruction of ancient human diet and health: implications for evolutionary medicine |
|
|
79 | (16) |
|
|
|
|
79 | (1) |
|
5.2 Stable isotope basics |
|
|
79 | (2) |
|
5.2.1 How stable isotope analysis reconstructs diet |
|
|
79 | (1) |
|
5.2.2 Stable isotopes, pathology and health |
|
|
80 | (1) |
|
5.3 Diet, pathology and evolutionary implications |
|
|
81 | (5) |
|
5.3.1 Hominin dietary ecology |
|
|
81 | (2) |
|
5.3.2 Intensification and agriculture |
|
|
83 | (1) |
|
5.3.3 Infant and early childhood diets |
|
|
84 | (2) |
|
5.4 Isotope applications in evolutionary medicine |
|
|
86 | (2) |
|
5.4.1 Stable isotope analysis for studying health in a modern context |
|
|
86 | (1) |
|
5.4.2 Carbon isotopes and obesogenic diets |
|
|
86 | (1) |
|
5.4.3 Nitrogen isotopes and early infant health |
|
|
87 | (1) |
|
5.5 Culturally sensitive and inclusive applications of evolutionary medicine |
|
|
88 | (1) |
|
5.5.1 Decolonising foodways: native foodways renaissance |
|
|
88 | (1) |
|
5.5.2 Decolonising foodways: translating USDA recommendations |
|
|
89 | (1) |
|
|
89 | (6) |
|
|
90 | (5) |
|
6 Developmental, evolutionary and behavioural perspectives on oral health |
|
|
95 | (25) |
|
|
|
6.1 Teeth as childhood record keepers |
|
|
95 | (5) |
|
6.1.1 Developmental disruptions begin at birth |
|
|
95 | (1) |
|
6.1.2 What can these disruptions tell us about childhood? |
|
|
96 | (3) |
|
6.1.3 Early life dental disruptions and disease |
|
|
99 | (1) |
|
6.1.4 Dental disruptions and early-life diets |
|
|
99 | (1) |
|
6.2 Those pesky wisdom teeth |
|
|
100 | (2) |
|
6.2.1 Why are M3 problems so common in some of us? |
|
|
101 | (1) |
|
6.3 Our teeth are never alone: the oral cavity as a microbial culture dish |
|
|
102 | (3) |
|
6.3.1 The oral microbiome in health |
|
|
102 | (1) |
|
6.3.2 The microbial biogeography of the oral cavity |
|
|
103 | (1) |
|
6.3.3 The formation of dental calculus |
|
|
104 | (1) |
|
6.4 Caries, gum disease and tooth loss: additional diseases of civilisation? |
|
|
105 | (6) |
|
6.4.1 Caries prevalence in the past |
|
|
105 | (2) |
|
6.4.2 Modern perspectives on caries |
|
|
107 | (1) |
|
6.4.3 Gum disease and tooth loss |
|
|
107 | (4) |
|
6.5 Use it or lose it: evolutionary and behavioural perspectives on orthodontics |
|
|
111 | (1) |
|
6.6 Conclusions and future directions |
|
|
112 | (8) |
|
|
113 | (7) |
|
7 Palaeoecology: considering proximate and ultimate influences on human diets and environmental responses in the early Holocene Dnieper River region of Ukraine |
|
|
120 | (18) |
|
|
|
|
120 | (3) |
|
|
121 | (2) |
|
7.2 Environments and health status along the Dnieper River |
|
|
123 | (7) |
|
|
125 | (1) |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
128 | (2) |
|
|
130 | (2) |
|
|
132 | (6) |
|
|
133 | (5) |
|
8 Human resistance and the evolution of plague in Medieval Europe |
|
|
138 | (17) |
|
|
|
8.1 Plague in the past and today |
|
|
138 | (4) |
|
8.1.1 History of the Black Death |
|
|
139 | (1) |
|
8.1.2 Consequences of the Black Death |
|
|
140 | (1) |
|
8.1.3 Differences between the Second and Third Pandemics |
|
|
140 | (2) |
|
8.1.4 Why study plague in the past? |
|
|
142 | (1) |
|
8.2 Ancient DNA analyses of medieval human populations |
|
|
142 | (3) |
|
8.2.1 Detecting plague in archaeological contexts |
|
|
142 | (1) |
|
8.2.2 Where has ancient plague DNA been found? |
|
|
143 | (2) |
|
8.2.3 What effect did the Black Death have on human genetic variation? |
|
|
145 | (1) |
|
8.3 Bioarchaeological analyses of plague |
|
|
145 | (3) |
|
8.3.1 Why was the Black Death so deadly? |
|
|
145 | (1) |
|
8.3.2 Who died during the Black Death? |
|
|
146 | (1) |
|
8.3.3 What effects did the Black Death have on health and demography? |
|
|
147 | (1) |
|
|
148 | (7) |
|
|
148 | (7) |
|
9 Leprosy is down but not yet out: new insights shed light on its origin and evolution |
|
|
155 | (24) |
|
|
|
|
|
155 | (1) |
|
9.2 Leprosy: present and past |
|
|
156 | (7) |
|
|
157 | (2) |
|
|
159 | (1) |
|
9.2.3 The immune system and leprosy |
|
|
159 | (2) |
|
|
161 | (1) |
|
|
162 | (1) |
|
9.3 The origin and evolution of leprosy |
|
|
163 | (5) |
|
|
168 | (1) |
|
|
168 | (1) |
|
|
169 | (2) |
|
|
171 | (8) |
|
|
171 | (8) |
|
10 Preventable and curable, but still a global problem: tuberculosis from an evolutionary perspective |
|
|
179 | (25) |
|
|
|
|
|
|
179 | (1) |
|
10.2 What is known about tuberculosis (TB) today |
|
|
180 | (4) |
|
10.2.1 How TB affects the body |
|
|
180 | (1) |
|
10.2.2 Epidemiology, prevention and treatment |
|
|
181 | (1) |
|
10.2.3 The genetics of TB |
|
|
182 | (2) |
|
10.3 What do we known about TB in the past? |
|
|
184 | (2) |
|
10.3.1 The evidence from paleopathology |
|
|
184 | (2) |
|
10.3.2 The evidence from aDNA analyses of the MTBC |
|
|
186 | (1) |
|
10.3 Synthesis of the skeletal and biomolecular evidence of TB from a global perspective |
|
|
186 | (4) |
|
10.3.1 The origin of TB: palaeopathological and ancient and modern molecular data |
|
|
186 | (2) |
|
10.3.2 TB and the epidemiological transitions |
|
|
188 | (1) |
|
10.3.3 Evidence for the distribution and spread of TB around the world |
|
|
189 | (1) |
|
|
190 | (3) |
|
|
193 | (11) |
|
|
193 | (11) |
|
11 Evolutionary perspectives on human parasitic infection: from ancient parasites to modern medicine |
|
|
204 | (18) |
|
|
|
|
204 | (1) |
|
11.2 Evidence for parasites throughout human history |
|
|
204 | (5) |
|
11.3 Human-parasite co-evolution |
|
|
209 | (2) |
|
11.3.1 Human evolution in response to parasite infection |
|
|
210 | (1) |
|
11.3.2 Parasite evolution in response to the human host |
|
|
210 | (1) |
|
11.4 Applications of palaeoparasitology and human-parasite evolution |
|
|
211 | (4) |
|
11.4.1 The hygiene hypothesis |
|
|
211 | (2) |
|
11.4.2 A role for palaeoparasitology |
|
|
213 | (2) |
|
|
215 | (7) |
|
|
215 | (7) |
|
12 Cardiovascular disease (CVD) in ancient people and contemporary implications |
|
|
222 | (17) |
|
|
|
|
|
|
|
|
|
|
222 | (2) |
|
12.2 The evidence for ancient CVD |
|
|
224 | (5) |
|
12.2.1 CT scans of ancient mummies |
|
|
224 | (2) |
|
12.2.2 Other evidence of atherosclerosis found in the remains of ancient people |
|
|
226 | (1) |
|
12.2.3 Unangan female of the Aleutian Islands |
|
|
227 | (2) |
|
12.3 Other CVDs seen in mummies |
|
|
229 | (1) |
|
|
230 | (1) |
|
|
230 | (9) |
|
|
232 | (7) |
|
13 Connecting paleopathology and evolutionary medicine to cancer research: past and present |
|
|
239 | (22) |
|
|
|
|
|
239 | (1) |
|
|
240 | (4) |
|
13.2.1 Proximate and ultimate perspectives on cancer biology |
|
|
240 | (4) |
|
13.2.2 Evolutionary mismatch and cancer |
|
|
244 | (1) |
|
13.3 Cancer in paleopathology |
|
|
244 | (5) |
|
13.3.1 Case study: can paleopathology provide information on temporal trends of cancer in ancient humans? |
|
|
246 | (3) |
|
13.4 Discussion: cancer is not new disease |
|
|
249 | (6) |
|
13.4.1 Cancer prevalence is underestimated in paleopathology |
|
|
251 | (1) |
|
13.4.2 An overview of the evolutionary mismatch |
|
|
252 | (1) |
|
13.4.3 The agricultural transition |
|
|
252 | (1) |
|
|
252 | (1) |
|
|
253 | (1) |
|
13.4.6 Toxins and carcinogens |
|
|
253 | (1) |
|
|
254 | (1) |
|
13.4.8 Increased adult survival |
|
|
254 | (1) |
|
13.4.9 Culture as a buffer |
|
|
255 | (1) |
|
13.5 Conclusion and future prospects |
|
|
255 | (6) |
|
|
256 | (5) |
|
14 Stress in bioarchaeology, epidemiology and evolutionary medicine: an integrated conceptual model of shared history from the descriptive to the developmental |
|
|
261 | (23) |
|
|
|
|
261 | (1) |
|
14.2 Starving animals and active glands: early models of stress in experimental settings |
|
|
261 | (1) |
|
14.3 From the lab to the field: formalised studies of stress and environment |
|
|
262 | (2) |
|
14.4 Beyond Cortisol: a multi-faceted approach to stress physiology |
|
|
264 | (1) |
|
14.5 Thrifty phenotypes, plasticity and constraint: the emergence of a life history perspective |
|
|
265 | (1) |
|
14.6 Stress in the past: foundational research in bioarchaeological approaches to physiological perturbation |
|
|
266 | (2) |
|
14.7 Paradox, promise and the life history framework: contemporary studies of stress in bioarchaeology |
|
|
268 | (5) |
|
14.7.1 Epidemiological modelling |
|
|
268 | (1) |
|
14.7.2 Skeletal frailty index |
|
|
269 | (1) |
|
14.7.3 Life course and life history perspectives |
|
|
270 | (1) |
|
14.7.4 Pathophysiological approaches |
|
|
271 | (2) |
|
|
273 | (11) |
|
|
274 | (10) |
|
15 Metabolic diseases in bioarchaeology: an evolutionary medicine approach |
|
|
284 | (19) |
|
|
|
|
|
|
|
284 | (1) |
|
15.2 Background to gout, DISH and Type 2 Diabetes Mellitus (T2DM) |
|
|
285 | (6) |
|
|
285 | (1) |
|
15.2.2 Bioarchaeological evidence of gout |
|
|
285 | (1) |
|
|
286 | (1) |
|
15.2.4 Skeletal evidence of DISH in the archaeological record |
|
|
287 | (1) |
|
|
288 | (1) |
|
15.2.6 Identifying T2DM in the archaeological record |
|
|
289 | (2) |
|
15.3 Models of the aetiology of metabolic disorders |
|
|
291 | (5) |
|
15.3.1 Ecological models of metabolic disease risk |
|
|
291 | (3) |
|
15.3.2 Life history approaches to understanding metabolic disease risk |
|
|
294 | (2) |
|
|
296 | (7) |
|
|
296 | (7) |
|
16 The paleopathology of traumatic injuries: an evolutionary medicine perspective |
|
|
303 | (14) |
|
|
|
16.1 An evolutionary medicine approach to traumatic injury in the past |
|
|
303 | (1) |
|
16.2 Understanding biomechanics and biology |
|
|
304 | (1) |
|
16.2.1 Biomechanics and tissue type |
|
|
304 | (1) |
|
16.3 The physiological impact of traumatic injuries |
|
|
305 | (1) |
|
16.4 Reconstructing an individual's lived experience |
|
|
306 | (1) |
|
16.5 Using paleopathology to understand trauma in the past |
|
|
307 | (2) |
|
16.6 Trauma as part of syndemics and the importance of the One Health approach |
|
|
309 | (1) |
|
|
310 | (7) |
|
|
311 | (6) |
|
17 Uncovering tales of transmission: an integrated palaeopathological perspective on the evolution of shared human and animal pathogens |
|
|
317 | (33) |
|
|
|
|
317 | (1) |
|
17.2 Shared pathogens in sparse populations: tapeworms (Taeniid sp.) in hunter-gatherers |
|
|
318 | (2) |
|
17.3 From sparse to crowded populations and from humans to animals to humans: the Mycobacterium tuberculosis complex |
|
|
320 | (4) |
|
17.4 Infection transmission by a vector: farming, urbanisation and the rise of Plasmodium falciparum as a human pathogen |
|
|
324 | (4) |
|
17.5 Herding, farming and warfare: transmission of shared intracellular bacterial pathogens: Brucella and Burkholderia mallei |
|
|
328 | (4) |
|
17.6 Urbanisation, war and conquest: morbilliviruses---shared pathogens in crowded environments |
|
|
332 | (4) |
|
|
336 | (14) |
|
|
339 | (11) |
|
18 Now that you have read the book, what next? |
|
|
350 | (4) |
|
|
|
|
|
|
352 | (2) |
Afterword |
|
354 | (2) |
|
Index |
|
356 | |